RONKONKOMA, N.Y.--(BUSINESS WIRE)--Prodose Inc., a newly established pharmaceutical company funded by Eversupplement, a Private Equity-backed platform, announces the launch of its advanced manufacturing and packaging facility in Ronkonkoma, New York. The company, which emerged as the highest bidder for select assets of Spirit Pharmaceuticals LLC in an auction conducted by Huntington Bank, is transforming the Orville Drive facility into a cutting-edge pharmaceutical operation, positioning itself as a leading provider of high-quality, affordable healthcare solutions.
With substantial capital investment from Eversupplement, Prodose Inc. is implementing an ambitious growth strategy that includes significant workforce expansion and technological advancement. Following the acquisition, the company conducted comprehensive performance evaluations and strategically rebuilt its workforce, ensuring compliance with New York State laws through proper WARN notice procedures. The company has already assembled a team of over 100 skilled professionals and is actively recruiting for executive positions across finance, regulatory affairs, and business development.
“Our launch represents a significant investment in both cutting-edge pharmaceutical capabilities and our local community,” said William Liggan, Vice President Human Resources at Prodose Inc. “We're building something special here in Ronkonkoma – a company that combines operational excellence with a deep commitment to making healthcare more accessible and affordable.”
“Our investment in Ronkonkoma goes beyond business – it's about creating sustainable economic growth and career opportunities in our community,” added Roshini Bakshi, a representative of Eversupplement. “We're proud to contribute to Long Island's manufacturing renaissance while advancing our mission of improving healthcare accessibility.”
Since taking over, several key changes to drive growth and enhance operational efficiency have been implemented. These initiatives include:
Expanding the product portfolio to include Vitamins, Minerals, and Supplements (VMS), Probiotics, Gummies, and Abbreviated New Drug Application (ANDA) over-the-counter (OTC) medications.
- Implementing advanced automation and serialization technology in packaging operations to increase efficiency and accuracy.
- Partnering with Ernst & Young to optimize operational efficiency and streamline processes.
- Developing a robust supply chain infrastructure with dual-sourcing strategies to mitigate risk and ensure business continuity.
- Pursuing DEA licensing to broaden manufacturing capabilities and enhance product offerings.
These strategic initiatives have been supported by significant capital investment from Eversupplement and the appointment of key C-suite executives, who bring extensive industry expertise and experience to the leadership team. The investment has been crucial in rebuilding operations and improving service delivery to previously underserved customers.
Prodose Inc.'s product line encompasses essential over-the-counter solutions for pain relief, allergies, digestive health, and common ailments. The company's state-of-the-art packaging technology positions it to serve both private-label and branded healthcare markets with superior quality and efficiency.
About Prodose Inc.
Prodose Inc. is an innovative pharmaceutical manufacturer specializing in high-quality, affordable healthcare solutions. Based in Ronkonkoma, NY, the company combines advanced manufacturing capabilities with a commitment to operational excellence and community investment. Prodose Inc. is positioned for sustained growth and leadership in the pharmaceutical industry.
